Appendix 1 Appendix: Pediatric Cardiovascular Anesthesia Drug Sheet (September 2022) 

# Appendix: Pediatric Cardiovascular Anesthesia Drug Sheet (September 2022)

_Lisa A. Caplan1 and Erin A. Gottlieb2_

1 Arthur S. Keats Division of Pediatric Cardiovascular Anesthesiology, Department of Anesthesiology, Baylor College of Medicine, Houston, TX, USA

2 Division of Pediatric Cardiac Anesthesiology, Department of Surgery and Perioperative Care, The University of Texas at Austin, Dell Children’s Medical Center of Central Texas, Associate Professor of Surgery and Perioperative Care Dell Medical School, Austin, TX, USA

Drug doses and treatments are those commonly recommended; each patient’s treatment must be individualized, drug doses double‐checked for accuracy, and drug concentrations and modes of administration used according to local guidelines. The information here is current at the time of publication; however, the practitioner must always be aware of new recommendations and remains responsible for determining the best course of treatment. Consult the textbook, hospital formulary, or authoritative internet resources for a complete listing of indications, contraindications, interval dosing schedules, and side‐effects of these drugs and treatments. All drugs are intravenous, unless otherwise noted. Drugs denoted with an asterisk (\*) are not approved by the US Food and Drug Administration (FDA) as of May 2021. Many drugs are not specifically labeled for pediatric use by the US FDA; however, the physician may choose to administer these drugs for specific indications, if in their judgment the drug will be safe and effective. The source for dosing information is the Texas Children's Hospital formulary, current as of May 2021, except as otherwise noted in the references.

<table border="1"><tbody><tr><td colspan="5" class="bgcolor1"><b>Vasoactive infusions</b></td></tr><tr><td class="left bgcolor1">Clevidipine <a href="#a1-bib-0001">[1]</a></td><td colspan="3" class="left bgcolor1">0.5–7 μg/kg/min</td><td colspan="5" class="left bgcolor1">Loading: 10–15 μg/kg</td></tr><tr><td class="left bgcolor1">Dobutamine</td><td colspan="3" class="bgcolor1">2–20 μg/kg/min</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Dopamine</td><td colspan="3" class="bgcolor1">2–20 μg/kg/min</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Epinephrine</td><td colspan="3" class="bgcolor1">0.03–1 μg/kg/min</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Esmolol</td><td colspan="3" class="bgcolor1">200–1000 μg/kg/min</td><td colspan="5" class="bgcolor1">Loading: 100–500 μg/kg</td></tr><tr><td class="left bgcolor1">Fenoldopam</td><td colspan="3" class="bgcolor1">0.1–0.8 μg/kg/min</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Isoproterenol</td><td colspan="3" class="bgcolor1">0.03–1 μg/kg/min</td><td colspan="5" class="bgcolor1">Maximum dose 2 μg/kg/min</td></tr><tr><td class="left bgcolor1">Levosimendan <a href="#a1-bib-0001">[2]</a>*</td><td colspan="3" class="bgcolor1">0.05–0.1 μg/kg/min</td><td colspan="5" class="bgcolor1">Loading: 6–12 μg/kg over 1 hour</td></tr><tr><td class="left bgcolor1">Liothyronine (Triostat<sup>®</sup>,T<sub>3</sub>) [<a href="#a1-bib-0003">3</a>, <a href="#a1-bib-0004">4</a>]</td><td colspan="3" class="bgcolor1">0.05–0.15 μg/kg/hour</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Milrinone</td><td colspan="3" class="bgcolor1">0.25–0.75 μg/kg/min</td><td colspan="5" class="bgcolor1">Loading: 50 μg/kg over 10–60 minutes</td></tr><tr><td class="left bgcolor1">Nesiritide</td><td colspan="3" class="bgcolor1">0.01 μg/kg/min; at intervals of 3 hours, dosage may be increased by 0.005 μg/kg/min to the maximum of 0.03 μg/kg/min</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Nicardipine</td><td colspan="3" class="bgcolor1">0.5–2 μg/kg/min</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Nitroglycerine</td><td colspan="3" class="bgcolor1">0.25–3 μg/kg/min</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Nitroprusside</td><td colspan="3" class="bgcolor1">0.3–3 μg/kg/min</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Norepinephrine</td><td colspan="3" class="bgcolor1">0.03–1 μg/kg/min</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Phenylephrine</td><td colspan="3" class="bgcolor1">0.05–0.5 μg/kg/min</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Prostaglandin E1</td><td colspan="3" class="bgcolor1">0.01–0.1 μg/kg/min</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Vasopressin</td><td colspan="3" class="bgcolor1">0.01–0.04 units/kg/hour</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1"><b>Vasoactive bolus drugs</b></td><td class="left bgcolor1" colspan="3"></td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Atropine</td><td colspan="3" class="bgcolor1">IV: 0.01–0.02 mg/kg<br>IM: 0.02 mg/kg</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Calcium chloride</td><td colspan="3" class="bgcolor1">10 mg/kg IV</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Calcium gluconate</td><td colspan="3" class="bgcolor1">30 mg/kg IV</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Enalaprilat</td><td colspan="3" class="bgcolor1">5–10 μg/kg/dose IV Q8–24H; max. 5 mg/dose</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Ephedrine</td><td colspan="3" class="bgcolor1">0.1 mg/kg IV max. 5 mg</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Epinephrine</td><td colspan="3" class="bgcolor1">0.5–10 μg/kg IV</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Hydralazine</td><td colspan="3" class="bgcolor1">0.1–0.2 mg/kg IV</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Labetalol</td><td colspan="3" class="bgcolor1">0.2–1 mg/kg IV</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Methylene blue [<a href="#a1-bib-0005">5</a>–<a href="#a1-bib-0007">7</a>]</td><td colspan="3" class="bgcolor1">1–2 mg/kg IV</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Phenoxybenzamine</td><td colspan="3" class="bgcolor1">0.25–1 mg/kg IV</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Phentolamine</td><td colspan="3" class="bgcolor1">0.05–0.2 mg/kg IV</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Phenylephrine</td><td colspan="3" class="bgcolor1">0.5–3 μg/kg IV</td><td colspan="5" class="bgcolor1"></td></tr><tr><td colspan="5" class="bgcolor1"><b>Antiarrhythmic agents</b></td></tr><tr><td class="left bgcolor1">Adenosine</td><td colspan="3" class="bgcolor1">First dose: 0.1 mg/kg IV (max 6 mg)</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1"></td><td colspan="3" class="bgcolor1">Second dose: 0.2 mg/kg IV (max dose 12 mg)</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Amiodarone</td><td colspan="3" class="bgcolor1">10–15 mg/kg/day</td><td colspan="5" class="bgcolor1">Loading: 2.5–5 mg/kg or a maximum of 300 mg IV over 5–10 minutes. Additional boluses of 5 mg/kg or a maximum of 150 mg IV push may be given with a maximum total dose not to exceed 25 mg/kg or 2.2 g in 24 hours</td></tr><tr><td class="left bgcolor1">Lidocaine</td><td colspan="3" class="bgcolor1">20–50 μg/kg/min</td><td colspan="5" class="bgcolor1">Loading: 1 mg/kg; repeat if the dose infusion is initiated more than 15 minutes after initial bolus</td></tr><tr><td class="left bgcolor1">Procainamide</td><td colspan="3" class="bgcolor1">20–80 μg/kg/min (max 2 g/day)</td><td colspan="5" class="bgcolor1">Loading: 3–6 mg/kg/dose over 5 minutes, not to exceed 100 mg/dose; may repeat every 5–10 minutes to the maximum total loading dose of 15 mg/kg; do not exceed 500 mg in 30 minutes</td></tr><tr><td class="left bgcolor1">Verapamil</td><td colspan="3" class="bgcolor1">0.1–0.3 mg/kg/dose (max. 5 mg) Repeat dose 30 minutes after the initial dose as needed (max second dose 10 mg)</td><td colspan="5" class="bgcolor1"></td></tr><tr><td colspan="5" class="bgcolor1"><b>Pulmonary hypertension medications</b></td></tr><tr><td class="left bgcolor1">Inhaled nitric oxide</td><td colspan="3" class="bgcolor1">1–20 PPM</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Epoprostenol <a href="#a1-bib-0008">[8]</a><br><br><br><br>Iloprost <a href="#a1-bib-0009">[9]</a><br><br>Sildenafil [<a href="#a1-bib-0010">10</a>, <a href="#a1-bib-0011">11</a>]<br>Treprostinil</td><td colspan="3" class="bgcolor1">Intravenous: 1–2 ng/kg/min initial infusion; increase by 1–2 ng/kg/min every 4–8 hours to 25–40 ng/kg/min; must be given in dedicated intravenous line<br>Inhaled: 20–50 ng?kg/min continuous infusion<br>Inhaled: Initial: 0.5 mcg/kg over 10 minutes<br>Subsequent Dosing: 1–2 mcg/kg over 10 minutes<br>0.067 mg/kg/hour; loading: 0.4 mg/kg over 3 hours<br>0.625–1.25 ng/kg/minute; must be given in dedicated intravenous<br>line</td><td colspan="5" class="bgcolor1"></td></tr><tr><td colspan="5" class="bgcolor1"><b>Anesthetic/analgesia agents</b></td></tr><tr><td class="left bgcolor1">Acetaminophen</td><td colspan="3" class="bgcolor1">10–15 mg/kg IV Q6 H</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Dexmedetomidine</td><td colspan="3" class="bgcolor1">0.25–0.75 μg/kg/hour</td><td colspan="5" class="bgcolor1">Loading: 0.25–1.0 μg/kg over 10 minutes</td></tr><tr><td class="left bgcolor1">Etomidate</td><td colspan="3" class="bgcolor1">0.2–0.3 mg/kg</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Fentanyl</td><td colspan="3" class="bgcolor1">1–10 μg/kg</td><td colspan="5" class="bgcolor1">Infusion: 1–10 μg/kg/hour</td></tr><tr><td class="left bgcolor1">Hydromorphone</td><td colspan="3" class="bgcolor1">0.005–0.015 mg/kg</td><td colspan="5" class="bgcolor1">Maximum single dose: 2 mg</td></tr><tr><td class="left bgcolor1">Ibuprofen</td><td colspan="3" class="bgcolor1">10 mg/kg IV Q6–8H</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Ketamine</td><td colspan="3" class="bgcolor1">IV: 1–2 mg/kg</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1"></td><td colspan="3" class="bgcolor1">IM: 5–10 mg/kg</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Ketorolac</td><td colspan="3" class="bgcolor1">0.5–1 mg/kg IV; 0.5 mg/kg/dose every 6 hours (max 30 mg/dose; 120 mg/day)</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Midazolam</td><td colspan="3" class="bgcolor1">0.03–0.1 mg/kg IV</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Morphine</td><td colspan="3" class="bgcolor1">0.05–0.2 mg/kg IV</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Remifentanil</td><td colspan="3" class="bgcolor1">0.025–2 μg/kg/min</td><td colspan="5" class="bgcolor1">Loading: 0.5–1 μg/kg IV</td></tr><tr><td class="left bgcolor1">Sufentanil</td><td colspan="3" class="bgcolor1">0.1–0.3 μg/kg/hour</td><td colspan="5" class="bgcolor1">Loading: 1–2 μg/kg IV</td></tr><tr><td colspan="5" class="bgcolor1"><b>Muscle relaxants (intubation dose) and reversal of neuromuscular blockade</b></td></tr><tr><td class="left bgcolor1">Atracurium</td><td colspan="3" class="bgcolor1">0.4–0.5 mg/kg IV</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Cisatracurium</td><td colspan="3" class="bgcolor1">0.1 mg/kg IV</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Pancuronium</td><td colspan="3" class="bgcolor1">0.1 mg/kg IV</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Rocuronium</td><td colspan="3" class="bgcolor1">0.6–1.2 mg/kg IV</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Succinylcholine</td><td colspan="3" class="bgcolor1">1–2 mg/kg IV; 4 mg/kg IM</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Vecuronium</td><td colspan="3" class="bgcolor1">0.08–0.1 mg/kg IV</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Neostigmine</td><td colspan="3" class="bgcolor1">50–70 μg/kg IV</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Glycopyrrolate</td><td colspan="3" class="bgcolor1">10–14 μg/kg IV (with neostigmine)</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Sugammadex <a href="#a1-bib-0012">[12]</a>*</td><td colspan="3" class="bgcolor1">Immediate reversal of rocuronium: 16 mg/kg<br>Deep block (1–2 post‐tetanic counts and prior to the second<br>twitch following train‐of‐four stimulation): 4 mg/kg<br>Moderate block (after appearance of the second twitch following<br>TOF stimulation): 2 mg/kg</td><td colspan="5" class="bgcolor1"></td></tr><tr><td colspan="5" class="bgcolor1"><b>Antibiotics</b></td></tr><tr><td class="left bgcolor1">Ampicillin</td><td colspan="3" class="bgcolor1">50 mg/kg IV (max 2 g)</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Cefazolin</td><td colspan="3" class="bgcolor1">25–30 mg/kg IV (max 1 g)</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Cefuroxime</td><td colspan="3" class="bgcolor1">25–50 mg/kg IV (max 1.5 g)</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Clindamycin</td><td colspan="3" class="bgcolor1">10–13 mg/kg IV (max 900 mg)</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Gentamicin</td><td colspan="3" class="bgcolor1">1–2.5 mg/kg IV (max 120 mg)</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Nafcillin</td><td colspan="3" class="bgcolor1">37.5–50 mg/kg IV (max 2 g)</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Piperacillin/tazobactam</td><td colspan="3" class="bgcolor1">50–100 mg/kg IV piperacillin component (max 16 g piperacillin<br>component/day)</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Vancomycin</td><td colspan="3" class="bgcolor1">10–15 mg/kg IV (max 1 g)</td><td colspan="5" class="bgcolor1"></td></tr><tr><td colspan="5" class="bgcolor1"><b>Antiemetics</b></td></tr><tr><td class="left bgcolor1">Dexamethasone<br>Metaclopromide</td><td colspan="3" class="bgcolor1">0.15–0.5 mg/kg IV<br>0.1–0.2 mg/kg/dose IV every 6–8 hours as needed (max. 10 mg)</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Ondansetron</td><td colspan="3" class="bgcolor1">0.1 mg/kg IV (max. 4 mg)</td><td colspan="5" class="bgcolor1"></td></tr><tr><td colspan="5" class="bgcolor1"><b>Corticosteroids</b></td></tr><tr><td class="left bgcolor1">Dexamethasone</td><td colspan="3" class="bgcolor1">Airway edema: 0.25–0.5 mg/kg IV</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Hydrocortisone</td><td colspan="3" class="bgcolor1">Adrenal insufficiency (stress dose): 50–100 mg/m<sup>2</sup>/dose IV</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1"></td><td colspan="3" class="bgcolor1">Anaphylaxis 0.5–2 mg/kg (max 250 mg)</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Methylprednisolone</td><td colspan="3" class="bgcolor1">20–30 mg/kg IV bolus or to bypass circuit</td><td colspan="5" class="bgcolor1"></td></tr><tr><td colspan="5" class="bgcolor1"><b>Diuretics</b></td></tr><tr><td class="left bgcolor1">Bumetanide</td><td colspan="3" class="bgcolor1">0.1 mg/kg/dose (IV or PO)</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Furosemide</td><td colspan="3" class="bgcolor1">0.5–1 mg/kg IV (max 20 mg)</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Mannitol</td><td colspan="3" class="bgcolor1">0.25–2 g/kg IV</td><td colspan="5" class="bgcolor1"></td></tr><tr><td colspan="5" class="bgcolor1"><b>Antifibrinolytics</b></td></tr><tr><td class="left bgcolor1">Tranexamic acid [<a href="#a1-bib-0013">13</a>, <a href="#a1-bib-0014">14</a>]</td><td colspan="3" class="bgcolor1">Neonate 0–2 mo.: 15 mg/kg bolus; 20 mcg/mL of CPB prime; 2.5 mg/kg/hour. infusion. Infant 2–12 mo.: 9 mg/kg bolus; 20 mcg/mL of CPB prime; 2 mg/kg/hour infusion. Child &gt; 12 mo.: 4 mg/kg bolus; 20 mcg/mL of CPB prime; 2 mg/kg/hour infusion.</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Aprotinin<a href="#a1-note-0001" id="R_a1-note-0001" aria-describedby="a1-note-0001" epub:type="noteref" role="doc-noteref"><sup><i>a</i></sup></a></td><td colspan="3" class="bgcolor1">28,000–60,000 KIU/kg bolus; 28,000–60,000 KIU/kg to CPB prime, 3,500–7,000 KIU/kg/hour infusion</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Epsilon aminocaproic acid <a href="#a1-bib-0015">[15]</a></td><td colspan="3" class="bgcolor1">Neonate 0–2 mo.: 40 mg/kg bolus; 0.1 mg/ml of CPB prime; 30 mg/kg/hour infusion. Infant 2–12 mo. and child &gt; 12 mo.: 75 mg/kg bolus; 75 mg/kg for CPB prime; 75 mg/kg/hour infusion.</td><td colspan="5" class="bgcolor1"></td></tr><tr><td colspan="5" class="bgcolor1"><b>Anticoagulants and reversal</b></td></tr><tr><td class="left bgcolor1">Bivalirudin [<a href="#a1-bib-0016">16</a>, <a href="#a1-bib-0017">17</a>]</td><td colspan="3" class="bgcolor1">For bypass: 1 mg/kg IV bolus; additional bolus of 0.1–0.5 mg/kg for subtherapeutic ACT; 50 mg to bypass circuit; infusion 2.5 mg/kg/hour<br>For ECMO or VAD: 0.1–0.2 mg/kg bolus; infusion 0.03–0.3 mg/kg/hour; monitor PTT hepzyme</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Heparin</td><td colspan="3" class="bgcolor1">300–400 units/kg (3–4 mg/kg) for CPB; 100 units/kg (1 mg/kg) for heparinization for non‐CPB cases (e.g. coarctation of the aorta, systemic‐to‐pulmonary artery shunt)</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Protamine</td><td colspan="3" class="bgcolor1">1–1.3 times heparin dose in mg</td><td colspan="5" class="bgcolor1"></td></tr><tr><td colspan="5" class="bgcolor1"><b>Electrolytes</b></td></tr><tr><td class="left bgcolor1">Sodium bicarbonate</td><td colspan="3" class="bgcolor1">1 mEq/kg; dilute 1 : 1 with sterile water for neonates</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">THAM (tromethamine)</td><td colspan="3" class="bgcolor1">1 mL/kg IV of 0.3 M solution; subsequent dosing based on blood gas result</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Potassium chloride</td><td colspan="3" class="bgcolor1">0.5–1 mEq/kg IV over 1 hour</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Magnesium sulfate</td><td colspan="3" class="bgcolor1">25–50 mg/kg IV over 1 hour</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Dextrose</td><td colspan="3" class="bgcolor1">For the treatment of hypoglycemia D<sub>10</sub>: 3–5 mL/kg IV for neonates</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1"></td><td colspan="3" class="bgcolor1">D<sub>25</sub>: 1–2 mL/kg IV for age 3 months to 2 years</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1"></td><td colspan="3" class="bgcolor1">D<sub>50</sub>: 0.5–1 mL/kg IV for age &gt; 2 years</td><td colspan="5" class="bgcolor1"></td></tr><tr><td colspan="5" class="bgcolor1"><b>Miscellaneous drugs</b></td></tr><tr><td class="left bgcolor1">Diphenhydramine</td><td colspan="3" class="bgcolor1">For acute hypersensitivity 1–2 mg/kg IV (max. 50 mg/dose)</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Flumazenil</td><td colspan="3" class="bgcolor1">1–5 μg/kg IV; repeat as necessary</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Levoalbuterol</td><td colspan="3" class="bgcolor1">4–8 puffs MDI through ETT; may repeat</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Naloxone</td><td colspan="3" class="bgcolor1">1–10 μg/kg IV; repeat as necessary</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Ranitidine</td><td colspan="3" class="bgcolor1">1 mg/kg IV</td><td colspan="5" class="bgcolor1"></td></tr><tr><td colspan="5" class="bgcolor1"><b>Oral/intranasal premedications</b></td></tr><tr><td class="left bgcolor1">Dexmedetomidine</td><td colspan="3" class="bgcolor1">Intranasal: 2 μg/kg</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Ketamine</td><td colspan="3" class="bgcolor1">Oral: 5–10 mg/kg</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Midazolam</td><td colspan="3" class="bgcolor1">Intranasal: 0.2 mg/kg over 15 seconds, may repeat in 5–15 minutes (max 15 mg)</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1"></td><td colspan="3" class="bgcolor1">Oral: 0.5–1 mg/kg</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Pentobarbital</td><td colspan="3" class="bgcolor1">Oral: 3–5 mg/kg</td><td colspan="5" class="bgcolor1"></td></tr><tr><td colspan="5" class="bgcolor1"><b>Maximum doses of local anesthetics</b><a href="#a1-note-0002" id="R_a1-note-0002" aria-describedby="a1-note-0002" epub:type="noteref" role="doc-noteref"><sup><i>b</i></sup></a></td></tr><tr><td class="left bgcolor1">Drug</td><td class="left bgcolor1">Spinal</td><td class="left bgcolor1">Caudal/Lumbar epidural</td><td class="left bgcolor1">Peripheral</td><td class="left bgcolor1">Subcutaneous</td></tr><tr><td class="left bgcolor1">Chlorprocaine</td><td class="left bgcolor1">NA</td><td class="left bgcolor1">8 mg/kg</td><td class="left bgcolor1">8 mg/kg</td><td class="left bgcolor1">8 mg/kg</td></tr><tr><td class="left bgcolor1">Chlorprocaine with epinephrine 1 : 200 K</td><td class="left bgcolor1">NA</td><td class="left bgcolor1">10 mg/kg</td><td class="left bgcolor1">10 mg/kg</td><td class="left bgcolor1">10 mg/kg</td></tr><tr><td class="left bgcolor1">Tetracaine</td><td class="left bgcolor1">0.2–0.6 mg/kg</td><td class="left bgcolor1">NA</td><td class="left bgcolor1">NA</td><td class="left bgcolor1">NA</td></tr><tr><td class="left bgcolor1">Lidocaine (0.5–1% infiltration), (1–2% peripheral, epidural, subcutaneous), (5% spinal)</td><td class="left bgcolor1">1–2.5 mg/kg</td><td class="left bgcolor1">5 mg/kg</td><td class="left bgcolor1">5 mg/kg</td><td class="left bgcolor1">5 mg/kg</td></tr><tr><td class="left bgcolor1">Lidocaine with epinephrine 1 : 200 K</td><td class="left bgcolor1">1–2.5 mg/kg</td><td class="left bgcolor1">7 mg/kg</td><td class="left bgcolor1">7 mg/kg</td><td class="left bgcolor1">7 mg/kg</td></tr><tr><td class="left bgcolor1">Bupivacaine (0.125–0.5% infiltration), (0.25–5% peripheral, epidural, subcutaneous)</td><td class="left bgcolor1">0.3–0.5 mg/kg</td><td class="left bgcolor1">2 mg/kg</td><td class="left bgcolor1">2 mg/kg</td><td class="left bgcolor1">2 mg/kg</td></tr><tr><td class="left bgcolor1">Bupivacaine with epinephrine 1 : 200 K</td><td class="left bgcolor1">0.3–0.5 mg/kg</td><td class="left bgcolor1">3 mg/kg</td><td class="left bgcolor1">3 mg/kg</td><td class="left bgcolor1">3 mg/kg</td></tr><tr><td class="left bgcolor1">Ropivacine (0.2–0.9% peripheral, epidural)</td><td class="left bgcolor1">NA</td><td class="left bgcolor1">2 mg/kg</td><td class="left bgcolor1">2 mg/kg</td><td class="left bgcolor1">2 mg/kg</td></tr><tr><td class="left bgcolor1">Ropivacine with epinephrine</td><td class="left bgcolor1">NA</td><td class="left bgcolor1">3 mg/kg</td><td class="left bgcolor1">3 mg/kg</td><td class="left bgcolor1">3 mg/kg</td></tr><tr><td class="left bgcolor1">Prilocaine (1–2% peripheral), (2–3% epidural)</td><td class="left bgcolor1">NA</td><td class="left bgcolor1">5 mg/kg</td><td class="left bgcolor1">5 mg/kg</td><td class="left bgcolor1">5 mg/kg</td></tr><tr><td class="left bgcolor1">Liposomal Bupivacine 1.3%</td><td class="left bgcolor1">NA</td><td class="left bgcolor1">NS</td><td class="left bgcolor1">NA</td><td class="left bgcolor1">3 mg/kg</td></tr><tr><td colspan="5" class="left bgcolor1"><b>Local anesthesthetic toxicity treatment</b></td></tr><tr><td class="left bgcolor1">20% Lipid emulsion <a href="#a1-bib-0018">[18]</a></td><td colspan="5" class="bgcolor1">Under 70 kg: Bolus 1.5 mL/kg over 2–3 minutes, start infusion at 0.25 mL/kg/hour;<br>If patient remains unstable, repeat bolus and double infusion rate, max dose 12 mL/kg<br>Over 70 kg: Bolus 100 mL over 2–3 minutes, infuse 250 mL over 15–20 minutes;<br>If patient remains unstable, repeat bolus and double infusion, max dose 12 mL/kg</td></tr><tr><td colspan="5" class="bgcolor1"><b>Blood products and volume expanders</b></td></tr><tr><td class="left bgcolor1">Albumin 5%</td><td colspan="3" class="bgcolor1">10–20 mL/kg IV</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Anti‐inhibitor coagulant complex (FEIBA<sup>®</sup>; activated prothrombin complex concentrate) [<a href="#a1-bib-0019">19</a>, <a href="#a1-bib-0020">20</a>]</td><td colspan="3" class="bgcolor1">50–100 units/kg; maximum rate of infusion 2 units/kg/min<br>10 units/kg IV, may repeat dose</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Cryoprecipitate</td><td colspan="3" class="bgcolor1">15 mL/5–10 kg IV</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Fibrinogen concentrate <a href="#a1-bib-0021">[21]</a></td><td colspan="3" class="bgcolor1">60–70 mg/kg when fibrinogen level is not known; when fibrinogen level is known Dose (mg/kg) = [100 (mg/dL) − measured level (mg/dL)] divided by 1.7</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Fresh frozen plasma</td><td colspan="3" class="bgcolor1">10–20 mL/kg IV</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Packed red blood cells</td><td colspan="3" class="bgcolor1">10–15 mL/kg IV</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Platelets</td><td colspan="3" class="bgcolor1">1 random unit/5 kg will increase platelet count by 50,000; 1 pheresis unit = 6 random units</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Prothrombin complex concentrate (Octaplex<sup>®</sup>, Kcentra<sup>®</sup>)</td><td colspan="3" class="bgcolor1">Pretreatment INR 2‐ <i>&lt;</i> 4: Administer 25 units/kg (max dose 2,500 units); Pretreatment INR 4–6: Administer 35 units/kg (max dose 3,500 units); Pretreatment INR &gt; 6: Administer 50 units/kg (max dose 5,000 units)<br>For postbypass coagulopathy: 25 units/kg IV</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Recombinant factor VIIa <a href="#a1-bib-0019">[19]</a></td><td colspan="3" class="bgcolor1">40–60 μg/kg IV; may repeat dose q 1–2 hours (max. Three total doses)</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">Whole blood</td><td colspan="3" class="bgcolor1">10–15 mL/kg IV</td><td colspan="5" class="bgcolor1"></td></tr><tr><td colspan="5" class="bgcolor1"><b>DC defibrillation/synchronized cardioversion</b></td></tr><tr><td class="left bgcolor1">Internal defibrillation</td><td colspan="3" class="bgcolor1">2 J, increase to 5 J, 10 J</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">External defibrillation</td><td colspan="3" class="bgcolor1">2–5 J/kg; increase if ineffective to max 200 J</td><td colspan="5" class="bgcolor1"></td></tr><tr><td class="left bgcolor1">External synchronized cardioversion</td><td colspan="3" class="bgcolor1"><span epub:type="pagebreak" id="Page_1028" role="doc-pagebreak" aria-label="1028"><span epub:type="pagebreak" id="Page_1029" role="doc-pagebreak" aria-label="1029"><span epub:type="pagebreak" id="Page_1030" role="doc-pagebreak" aria-label="1030">0.5 J/kg; increase if ineffective to 1 J/kg</span></span></span></td><td class="left bgcolor1" colspan="5"></td></tr></tbody></table>

[_a_](#R_a1-note-0001) Aprotinin was not available in the USA as of December 2007.

[_b_](#R_a1-note-0002) TCH EPIC dose calculator, September 2022.

## References

1.  1 Tobias JD, Schechter WS, Phillips A, et al. Clevidipine for perioperative blood pressure control in infants and children undergoing cardiac surgery for congenital heart disease. J Pediatr Pharmacol Ther 2011; 16:55–60.
2.  2 Ricci Z, Garisto C, Favia I, et al. Levosimendan infusion in newborns after corrective surgery for congenital heart disease: randomized controlled trial. Intensive Care Med 2012; 38:1198–204.
3.  3 Chowdhury D, Ojamaa K, Parnell VA, et al. A prospective randomized clinical study of thyroid hormone treatment afteroperations for complex congenital heart disease. J Thorac Cardiovasc Surg 2001; 122:1023–5.
4.  4 Mackie AS, Booth KL, Newburger JW, et al. A randomized, double‐blind, placebo‐controlled pilot trial of triiodothyronine in neonatal heart surgery. J Thorac Cardiovasc Surg 2005; 130:810–6.
5.  5 Fischer GW, Levin MA. Vasoplegia during cardiac surgery: current concepts and management. Semin Thoracic Surg 2010; 22:140–4.
6.  6 Bhalla T, Sawardekar A, Russell H, Tobias JD. The role of methylene blue in the pediatric patient with vasoplegic syndrome. World J Pediatr Congenit Heart Surg 2011; 2:652–5.
7.  7 Shanmugam G. Vasoplegic syndrome – the role of methylene blue. Eur J Cardiothorac Surg 2005; 28:705–10.
8.  8 Dahlem P, van Aalderen WM, de Neef M, et al. Randomized controlled trial of aerosolized prostacyclin therapy in children with acute lung injury. Crit Care Med 2004; 32(4):1055–60.
9.  9 Limsuwan A, Wanitkul S, Khosithset A, et al. Aerosolized iloprost for postoperative pulmonary hypertensive crisis in children with congenital heart disease. Int J Cardiol 2008; 129(3):333–8.
10.  10 Steinhorn RH, Kinsella JP, Pierce C, et al. Intravenous sildenafil in the treatment of neonates with persistent pulmonary hypertension. J Pediatr 2009; 155:841–7.
11.  11 Stocker C, Penny DJ, Brizard CP, et al. Intravenous sildenafil and inhaled nitric oxide: a randomized trial in infants after cardiac surgery. Intensive Care Med 2003; 29:1996–2003.
12.  12 Geldner G, Niskanen M, Laurila P, et al. A randomised controlled trial comparing sugammadex and neostigmine at different depths of neuromuscular blockade in patients undergoing laparoscopic surgery. Anaesthesia 2012; 67(9):991–8.
13.  13 Grassin‐Delyle S, Couturier R, Abe E, et al. A practical tranexamic acid dosing scheme based on population pharmacokinetics in children undergoing cardiac surgery. Anesthesiology 2013; 118:853–62.
14.  14 Wesley MC, Pereira LM, Scharp LA, et al. Pharmacokinetics of tranexamic acid in neonates, infants, and children undergoing cardiac surgery with cardiopulmonary bypass. Anesthesiology 2015; 122:746–58.
15.  15 Eaton MP, Alfieris GM, Sweeney DM, et al. Pharmacokinetics of epsilon‐aminocaproic acid in neonates undergoing cardiac surgery with cardiopulmonary bypass. Anesthesiology 2015; 122:1002–9.
16.  16 Almond CSD, Harrington J, Thiagarajan R, et al. Successful use of bivalirudin for cardiac transplantation in a child with heparin‐induced thrombocytopenia. J Heart Lung Transplant 2006; 25:1376–9.
17.  17 Ahmed M, Adachi I, Teruya J. Chapter 59: Anticoagulation. In: Mery CM, Bastero P, Hall SR, et al. (eds) The Texas Children's Hospital Handbook of Congenital Heart Disease, Houston, TX: Texas Children's Hospital, 2020, p. 447.
18.  18 Neal JM, Neal J, Weinberg GL. American society of regional anesthesia and pain management local anesthetic systemic toxicity checklist: 2020 version. Reg Anesth Pain Med 2021; 46:81–2.
19.  19 Carroll RB, Zaki H, McCracken C, et al. Use of factor viia amd anti‐inhibitor coagulant complex in pediatric cardiac surgery patients. J Pediatr Pharmacol Ther 2020; 25:540–6.
20.  20 Maeda K, Asija R, Hollander S, et al. Low dose factor eight inhibitor bypassing activity (FEIBA) for incessant bleeding in pediatric patients on mechanical circulatory support (MCS). J Heart and Lung Transplantation 2013; 32:S290.
21.  21 Galas FR, de Almeida JP, Fukushima JP, et al. Hemostatic effects of fibrinogen concentrate compared with cryoprecipitate in children after cardiac surgery: a randomized pilot trial. J Thorac Cardiovasc Surg 2014; 148:1647–55.